Cargando…
SMN1 dosage analysis in spinal muscular atrophy from India
BACKGROUND: Spinal muscular atrophy (SMA) represents the second most common fatal autosomal recessive disorder after cystic fibrosis. Due to the high carrier frequency, the burden of this genetic disorder is very heavy in developing countries like India. As there is no cure or effective treatment, g...
Autores principales: | Kesari, Akanchha, Rennert, Hanna, Leonard, Debra GB, Mittal, Balraj |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174872/ https://www.ncbi.nlm.nih.gov/pubmed/15910686 http://dx.doi.org/10.1186/1471-2350-6-22 |
Ejemplares similares
-
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
por: Bowerman, Melissa, et al.
Publicado: (2017) -
SMN post-translational modifications in spinal muscular atrophy
por: Riboldi, Giulietta M., et al.
Publicado: (2023) -
Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
por: Šoltić, Darija, et al.
Publicado: (2020) -
Rapid molecular diagnosis of spinal muscular atrophy
por: Mittal, Balraj
Publicado: (2012) -
Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets
por: Tsai, Li-Kai
Publicado: (2012)